TD Waterhouse Canada Inc. Buys 215,666 Shares of MetLife, Inc. $MET

TD Waterhouse Canada Inc. increased its stake in MetLife, Inc. (NYSE:MET) by 136.5% in the third quarter, Holdings Channel reports. The institutional investor owned 373,636 shares of the financial services provider’s stock after acquiring an additional 215,666 shares during the period. TD Waterhouse Canada Inc.’s holdings in MetLife were worth $35,280,000 at the end of the most recent quarter.

A number of other institutional investors also recently bought and sold shares of the stock. Pension & Wealth Management Advisors Inc. increased its position in MetLife by 62.0% during the third quarter. Pension & Wealth Management Advisors Inc. now owns 810 shares of the financial services provider’s stock valued at $76,000 after acquiring an additional 310 shares during the last quarter. Cantor Fitzgerald Investment Advisors L.P. lifted its holdings in shares of MetLife by 2.1% in the 3rd quarter. Cantor Fitzgerald Investment Advisors L.P. now owns 175,989 shares of the financial services provider’s stock worth $16,571,000 after acquiring an additional 3,557 shares during the last quarter. V Square Quantitative Management LLC boosted its stake in shares of MetLife by 0.5% during the 3rd quarter. V Square Quantitative Management LLC now owns 40,436 shares of the financial services provider’s stock worth $3,807,000 after purchasing an additional 200 shares during the period. AdvisorNet Financial Inc boosted its stake in shares of MetLife by 40.5% during the 3rd quarter. AdvisorNet Financial Inc now owns 2,088 shares of the financial services provider’s stock worth $208,000 after purchasing an additional 602 shares during the period. Finally, Nvwm LLC grew its holdings in MetLife by 655.3% during the 3rd quarter. Nvwm LLC now owns 287 shares of the financial services provider’s stock valued at $27,000 after purchasing an additional 249 shares during the last quarter. 94.99% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

MET has been the topic of a number of recent analyst reports. Barclays increased their price objective on shares of MetLife from $97.00 to $111.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 7th. TD Cowen raised their price objective on shares of MetLife from $105.00 to $110.00 and gave the stock a “buy” rating in a research note on Monday, October 5th. Bank of America dropped their target price on MetLife from $106.00 to $103.00 and set a “buy” rating for the company in a research report on Wednesday, July 15th. Weiss Ratings reaffirmed a “buy (b)” rating on shares of MetLife in a research note on Friday, September 11th. Finally, Atlantic Securities set a $103.00 target price on MetLife in a research note on Wednesday, July 15th. Thirteen equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $105.19.

MetLife Stock Performance

MET stock opened at $100.73 on Friday. MetLife, Inc. has a twelve month low of $67.33 and a twelve month high of $102.43. The firm has a market cap of $64.82 billion, a price-to-earnings ratio of 19.30, a PEG ratio of 0.95 and a beta of 0.78. The business’s fifty day simple moving average is $96.87 and its two-hundred day simple moving average is $88.73. The company has a quick ratio of 0.20, a current ratio of 0.20 and a debt-to-equity ratio of 0.52.

MetLife (NYSE:MET) last issued its earnings results on Wednesday, August 5th. The financial services provider reported $2.43 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.30 by $0.13. The firm had revenue of $13.52 billion during the quarter, compared to analyst estimates of $19.67 billion. MetLife had a net margin of 4.57% and a return on equity of 23.39%. The business’s revenue was up 10.5% on a year-over-year basis. During the same period in the previous year, the firm earned $2.02 earnings per share. Analysts predict that MetLife, Inc. will post 9.93 earnings per share for the current year.

MetLife Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 8th. Investors of record on Tuesday, November 3rd will be paid a $0.5925 dividend. This represents a $2.37 annualized dividend and a yield of 2.4%. The ex-dividend date of this dividend is Tuesday, November 3rd. MetLife’s dividend payout ratio (DPR) is currently 45.40%.

MetLife announced that its board has initiated a stock repurchase plan on Wednesday, August 5th that authorizes the company to repurchase $3.00 billion in shares. This repurchase authorization authorizes the financial services provider to reacquire up to 4.8% of its stock through open market purchases. Share repurchase plans are usually a sign that the company’s leadership believes its stock is undervalued.

Key MetLife News

Here are the key news stories impacting MetLife this week:

• Positive Sentiment: JPMorgan raised its price target for MetLife from $108 to $110 and maintained an “overweight” rating. The new target implies approximately 9% upside from the referenced share price, signaling continued confidence in MetLife’s earnings outlook and valuation.
• Positive Sentiment: Dowling & Partners increased its FY2026 EPS forecast to $10.30 from $10.10. The revised estimate is also above the broader consensus forecast of $9.90, suggesting expectations for stronger profitability. MetLife Hits New 52-Week High on Analyst Upgrade
• Positive Sentiment: MetLife reached a new 52-week high following an analyst upgrade. The move reflects sustained investor demand and momentum around the insurer’s earnings performance and analyst outlook. MetLife Hits New 52-Week High on Analyst Upgrade
• Positive Sentiment: Brokerages’ consensus price target is reported at $105.06, providing additional evidence that analysts see potential upside for MET. MetLife Consensus Price Target
• Neutral Sentiment: MetLife Foundation awarded a $1 million grant to Ascendus for its Get Ready program. The initiative supports financial preparedness and may enhance MetLife’s corporate reputation, but it is unlikely to materially affect near-term earnings. Ascendus Expands Get Ready Program
• Neutral Sentiment: Articles about concerts, NFL venues and events at MetLife Stadium concern the stadium’s entertainment operations, not MetLife, Inc.’s insurance and financial-services business, so they are not expected to influence MET materially.

MetLife Company Profile

MetLife, Inc (NYSE: MET) is a global financial services company that provides insurance, retirement, and employee benefits solutions to individuals, employers, and institutions. Its offerings include life insurance, dental and vision coverage, accident and disability insurance, annuities, retirement savings products, and related financial services.

Through its institutional and workplace businesses, MetLife helps employers provide benefits and retirement programs to their employees. The company also serves individual customers with protection and income products.